Sources | Names Used |
---|---|
CTRPv2 | ISOX:bortezomib (250:1 mol/mol) |
PharmacoGx | ISOX:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.29 | 6e-13 |
mRNA | IQGAP1 | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-11 |
mRNA | MEX3A | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-11 |
mRNA | S100A10 | CTRPv2 | pan-cancer | AAC | -0.24 | 3e-10 |
mRNA | ADAM22 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
mRNA | SHPRH | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-09 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | CHD4 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | HDAC2 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |